Skip to Content

'
Vicente Valero, M.D., F.A.C.P.

Present Title & Affiliation

Primary Appointment

Deputy Chairman, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Professor of Medicine, Department of Breast Medical Oncology, Division of Cancer Medicine, UTMDACC, Houston, TX

Dual/Joint/Adjunct Appointment

Professor, Department of General Oncology, Division of Cancer Medicine, General Oncology Department, Houston, TX

Education & Training

Degree-Granting Education

1980 Universidad Autonoma de Nuevo Leon, Facultad de Medicina, Monterrey, Nuevo Leon, Mexico, MD, Medicine

Postgraduate Training

7/1987-6/1988 Fellow, Hematology-Medical Oncology, Medical Oncology, University of Texas Medical Branch, Department of Medicine, Galveston, TX, Frank H. Gardner MD
7/1985-6/1987 Fellow, Hematology-Medical Oncology, Medical Oncology, University of Cincinnati Medical Center and Veterans Administration Hospital, Cincinnati, OH, Orlando Martelo MD
7/1982-6/1985 Internal Medicine: Resident, Internal Medicine, Saint Elizabeth Hospital Medical Center, Youngstown, OH, Charles Wilkins MD
7/1982-6/1985 Internal Medicine: Resident, Internal Medicine, Northeastern Ohio University College of Medicine, Rootstown, OH, Charles Wilkins MD

Selected Publications

Peer-Reviewed Original Research Articles
1. Lu J, Steeg PS, Price JE, Krishnamurthy S, Mani SA, Reuben J, Cristofanilli M, Dontu G, Bidaut L, Valero V, Hortobagyi GN, Yu D. Breast Cancer Metastasis: Challenges and Opportunities. Cancer Res 69(12):4951-3, Jun 15, 6/2009. e-Pub 5/2009. PMID: 19470768.
2. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J, Sahin A, Agarwal R, Joy C, Liu W, Stivers D, Baggerly K, Carey M, Lluch A, Monteagudo C, He X, Weigman V, Fan C, Palazzo J, Hortobagyi GN, Nolden LK, Wang NJ, Valero V, Gray JW, Perou CM, Mills GB. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69(10):4116-24, 5/2009. e-Pub 5/2009. PMID: 19435916.
3. Liedtke C, Hatzis C, Symmans WF, Desmedt C, Haibe-Kains B, Valero V, Kuerer H, Hortobagyi GN, Piccart-Gebhart M, Sotiriou C, Pusztai L. Genomic Grade Index Is Associated With Response to Chemotherapy in Patients With Breast Cancer. J Clin Oncol. e-Pub 4/13/2009. PMID: 19364972.
4. Dawood S, Broglio K, Valero V, Reuben J, Handy B, Islam R, Jackson S, Hortobagyi GN, Fritsche H, Cristofanilli M. Circulating tumor cells in metastatic breast cancer: from prognostic stratification to modification of the staging system? Cancer 113(9):2422-30, 11/2008. PMID: 18785255.
5. Brewster A, Hortobagyi GN, Broglio RK, Kau S, Santa-Maria CA, Arun B, Buzdar A, Booser D, Valero V, Bondy M, Esteva F. Residual Risk of Breast Cancer Recurrence 5 years After Adjuvant Therapy. J Natl Cancer Inst 100(16):1-5, 2008. e-Pub 2/2008. PMID: 18695137.
6. Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, Rouzier R, Broglio KR, Hortobagyi GN, Valero V. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol 25(31):4952-60, 11/2007. PMID: 17971593.
7. Arun B, Valero V, Logan C, Broglio K, Rivera E, Brewster A, Yin G, Green M, Kuerer H, Gong Y, Browne D, Hortobagyi GN, Sneige N. Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials. Clin Cancer Res 13:4943-4948, 8/2007. PMID: 17699874.
8. Gong Y, Yan K, Lin F, Anderson K, Sotiriou C, Andre F, Holmes FA, Valero V, Booser D, Pippen JE, Jr., Vukelja S, Gomez H, Mejia J, Barajas LJ, Hess KR, Sneige N, Hortobagyi GN, Pusztai L, Symmans WF. Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study. Lancet Oncol 8:203-11, 3/2007. PMID: 17329190.
9. Hess KR, Anderson K, Symmans WF, Valero V, Ibrahim N, Mejia JA, Booser D, Theriault RL, Buzdar AU, Dempsey PJ, Rouzier R, Sneige N, Ross JS, Vidaurre T, Gomez HL, Hortobagyi GN, Pusztai L. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with Paclitaxel and Fluorouracil, Doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol 24(26):4236-44, 9/2006. PMID: 16896004.
10. Hanrahan EO, Valero V, Gonzalez-Angulo AM, Hortobagyi GN. Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature. J Clin Oncol 24:2113-22, 5/2006. PMID: 16648513.
11. Hennessy BT, Giordano S, Broglio K, Duan Z, Trent J, Buchholz TA, Babiera G, Hortobagyi GN, Valero V. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol 17:605-13, 4/2006. PMID: 16469754.
12. Hennessy BT, Hortobagyi GN, Rouzier R, Kuerer H, Sneige N, Buzdar AU, Kau SW, Fornage B, Sahin A, Broglio K, Singletary SE, Valero V. Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 23:9304-11, 12/2005. PMID: 16361629.
13. Ewer MS, Vooletich MT, Durand JB, Woods ML, Davis JR, Valero V, Lenihan DJ. Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment. J Clin Oncol 23:7820-6, 11/2005. PMID: 16258084.

Last updated: 10/20/2009